In this study we we assess the repeatability of VERDICT (Vascular, Extracellular, and Restricted Diffusion for Cytometry in Tumours) MRI parameters in prostate cancer consider their ability to distinguish between Gleason grades compared with the standard ADC model in 71 patients. Four of the parametric maps derived from the VERDICT technique were found to be satisfactorily repeatable for use as a clinical tool, and are capable of identifying a Gleason 7 component in prostate cancer where ADC failed to do so. VERDICT therefore holds great potential for use in clinical prostate cancer management pathways in the future.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords